{"id":"W2168385579","doi":"10.1177/2040620715586528","title":"Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Hematology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Obinutuzumab; Medicine; Rituximab; Fludarabine; Chronic lymphocytic leukemia; Oncology; Internal medicine; Chemotherapy; Cyclophosphamide; Leukemia; Venetoclax; Immunology; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002395892,0.0006522856,0.003503064,0.0002363926,0.000067041,0.00001025893,0.000278177,0.000371492,0.00003095643],"category_scores_gemma":[0.00006812648,0.0003335607,0.0002750061,0.0005128421,0.0007770278,0.0000837588,0.00005923505,0.0002204369,0.000007972583],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.1830799,"about_ca_system_score_gemma":0.04559017,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003293423,"about_ca_topic_score_gemma":0.0002451775,"domain_scores_codex":[0.9971879,0.0002304171,0.0008023535,0.0007231907,0.0003734701,0.0006826922],"domain_scores_gemma":[0.9963374,0.00178498,0.0005101166,0.0008649696,0.0003688798,0.0001336125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001265346,0.0001652323,0.00003134321,0.02789124,0.001251924,0.00005465818,0.0007163818,0.0000613376,1.89462e-8,0.004628184,0.00001029077,0.9639241],"study_design_scores_gemma":[0.03788437,0.006785625,0.000005629139,0.01018444,0.004384061,0.0008189679,0.000236274,0.001341279,0.000004569803,0.00115199,0.9367802,0.0004226201],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003033878,0.9920673,0.00008973394,0.00001444338,0.0001019583,0.007191779,0.00005043616,0.00003431863,0.0001466091],"genre_scores_gemma":[0.001261226,0.9965869,0.0001192653,0.00002341544,0.00007277459,0.001574978,0.00008937774,0.0001039372,0.0001681287],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9635014,"threshold_uncertainty_score":0.9999117,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06151108374895914,"score_gpt":0.4038393252012171,"score_spread":0.3423282414522579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}